621 - 630 of 8808 Results
Title
Year
-
RESTRICTEDTitle: Novel therapeutic approaches to target neurodegenerationJournal Name: British Journal of PharmacologyPublisher: WileyVol: 180Issue #: 13Start Page: 1651End Page: 1673Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1111/bph.16078Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bph.16078Citation Count: 7
-
RESTRICTEDTitle: Huntington disease: A quarter century of progress since the gene discoveryJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 396Issue #:Start Page: 52End Page: 68Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2018.09.022Citation Count: 59
-
RESTRICTEDTitle: REM Sleep Behavior and Motor Findings in Parkinson's Disease: A Cross-sectional Analysis.Journal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.7916/d84b2zdfCitation Count: 4
-
RESTRICTEDTitle: Juvenile parkinsonism: Differential diagnosis, genetics, and treatmentJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 67Issue #:Start Page: 74End Page: 89Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.06.025Citation Count: 67
-
RESTRICTEDTitle: Biomarker candidates of neurodegeneration in Parkinson’s disease for the evaluation of disease-modifying therapeuticsJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 119Issue #: 1Start Page: 39End Page: 52Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s00702-011-0682-xBest OA location URL: https://link.springer.com/content/pdf/10.1007/s00702-011-0682-x.pdfCitation Count: 68
-
RESTRICTEDTitle: Digital technologies: Innovations that transform the face of drug developmentJournal Name: Clinical and Translational SciencePublisher: WileyVol: 16Issue #: 8Start Page: 1323End Page: 1330Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1111/cts.13533Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cts.13533Citation Count: 2
-
RESTRICTEDTitle: Serotonergic Approaches in Parkinson’s Disease: Translational Perspectives, an UpdateJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 8Issue #: 5Start Page: 973End Page: 986Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.6b00440Citation Count: 34
-
RESTRICTEDTitle: Unmet needs in Parkinson disease: Motor and non-motorJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 80Issue #:Start Page: S7End Page: S12Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.09.024Best OA location URL: http://www.prd-journal.com/article/S1353802020307380/pdfCitation Count: 60
-
RESTRICTEDTitle: Specific immune modulation of experimental colitis drives enteric alpha-synuclein accumulation and triggers age-related Parkinson-like brain pathology.Journal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.17879/freeneuropathology-2021-3326Citation Count: 7
-
RESTRICTEDTitle: γ‐Synuclein and the progression of cancerJournal Name: The FASEB JournalPublisher: WileyVol: 21Issue #: 13Start Page: 3419End Page: 3430Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1096/fj.07-8379revCitation Count: 91